Principal Financial Group
VERA icon

Principal Financial Group’s Vera Therapeutics VERA Stock Holding History

Principal Financial Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,230
Closed -$262K – 2411
2024
Q2 		$262K Sell
7,230
-6,237
-46% -$247K ﹤0.01% 2086
2024
Q1 		$581K Buy
13,467
+147
+1% +$5.24K ﹤0.01% 1955
2023
Q4 		$205K Sell
13,320
-451
-3% -$5.73K ﹤0.01% 2165
2023
Q3 		$189K Buy
13,771
+533
+4% +$9.14K ﹤0.01% 2177
2023
Q2 		$212K Buy
+13,238
New +$120K ﹤0.01% 2167

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group's VERA Position: Q3 2024 in Review

Principal Financial Group sold out of Vera Therapeutics (VERA) in Q3 2024, closing a stake of 7,230 shares — an estimated $262K sold.

Principal Financial Group first reported a position in VERA in Q2 2023 and held it in 5 quarters. The position peaked at $581K in Q1 2024. 173 funds tracked by Wall St. Rank hold VERA as of Q3 2024.

  • Principal Financial Group reported no remaining Vera Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 7,230 Vera Therapeutics shares in Q3 2024, an estimated $262K.
  • Principal Financial Group first reported a position in Vera Therapeutics in Q2 2023 and held it in 5 quarters.
  • Principal Financial Group's Vera Therapeutics position peaked at $581K in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.